• Bufalin: Cardiotonics Driving Advanced Cancer Research Workf

  2026-06-02

  Bufalin, a cardiotonic steroid from APExBIO, is redefining experimental cancer research by enabling precise molecular degradation and apoptosis induction in triple-negative breast cancer models. Discover optimized workflows, troubleshooting insights, and innovative protocol enhancements for leveraging Bufalin’s unique mechanisms in translational oncology.

• Alpha-Ketoglutarate in Metabolic Reprogramming: Protocols &

  2026-06-01

  Alpha-ketoglutarate (α-KGA) is revolutionizing metabolic reprogramming research with its dual roles in mitochondrial metabolism and immune modulation. This article delivers actionable workflows, troubleshooting strategies, and experimental insights drawn from cutting-edge tumor microenvironment studies and the latest protocol innovations.

• Caspase-3 Fluorometric Assay Kit: Decoding PARP1 Cleavage an

  2026-06-01

  Explore how the Caspase-3 Fluorometric Assay Kit enables advanced investigation of PARP1 cleavage and ferroptosis-apoptosis crosstalk in cancer biology. This article provides a distinct, mechanism-focused perspective on caspase-3 assay selection and interpretation.

• Q-VD(OMe)-OPh: Advancing Caspase Inhibition for Translationa

  2026-05-31

  Explore how Q-VD(OMe)-OPh transforms apoptosis research through precise, low-toxicity pan-caspase inhibition. This article offers a deep analysis of assay design, mechanistic selectivity, and translational impact, with reference to current breakthroughs and practical protocol insights.

• Amiloride (MK-870): Optimizing Sodium Channel and Endocytosi

  2026-05-30

  Amiloride (MK-870) is a dual-action inhibitor that enables precise interrogation of epithelial sodium channel and uPAR-mediated signaling in diverse cellular contexts. This guide delivers advanced protocols, troubleshooting insights, and actionable tips to accelerate ion transport and endocytosis research with APExBIO's rigorously benchmarked reagent.

• Fosinopril Sodium: Optimizing ACE Inhibition in Hypertension

  2026-05-29

  Fosinopril sodium enables reliable, high-sensitivity ACE inhibition assays with reproducible modulation of blood pressure and renal hemodynamics. Learn how to maximize its potential in cardiovascular disease models with evidence-backed protocol enhancements, troubleshooting insights, and guidance rooted in the latest translational research.

• HyperPFU™ High-Fidelity DNA Polymerase: Technical Use Guide

  2026-05-29

  HyperPFU™ high-fidelity DNA polymerase (APExBIO SKU K1031) is designed for accurate PCR amplification of long, GC-rich, or otherwise challenging DNA templates where standard enzymes may fail due to low fidelity or poor processivity. It is best suited for workflows requiring blunt-ended, error-minimized DNA products, but is not appropriate for protocols dependent on 3'-A overhangs or sticky-end ligations.

• KPT-330 (Selinexor): Optimizing CRM1 Inhibition in Cancer Re

  2026-05-28

  KPT-330 (Selinexor) stands at the forefront of targeted oncology research, enabling apoptosis induction and tumor growth inhibition through selective CRM1 blockade. This article delivers practical, evidence-driven workflows and troubleshooting strategies to maximize KPT-330’s impact in cancer cell and in vivo models.

• Probenecid (4-(dipropylsulfamoyl)benzoic acid): Applied Work

  2026-05-28

  Probenecid is more than a transporter inhibitor: it empowers high-impact workflows in multidrug resistance reversal and neuroprotection models. Explore evidence-backed protocols, troubleshooting strategies, and translational considerations for 4-(dipropylsulfamoyl)benzoic acid from APExBIO.

• Tofacitinib (CP-690550): Advanced Workflows for Immune Modul

  2026-05-27

  Tofacitinib (CP-690550) enables precise, multi-modal blockade of inflammatory cytokine signaling and mitochondrial repair in immune cell assays. Its ability to reverse GM-CSF-driven dysfunction in RA macrophages distinguishes it from conventional anti-cytokine or metabolic therapies, making it an indispensable tool for translational immune modulation research.

• Gramine Induces Ferroptosis in TNBC via CUL3–MTDH Ubiquitina

  2026-05-27

  This study reveals that gramine, a natural indole alkaloid, suppresses triple-negative breast cancer (TNBC) by inducing ferroptosis through CUL3-mediated ubiquitination of MTDH. The work provides a mechanistic foundation for targeting the CUL3–MTDH axis in ferroptosis-based TNBC therapies and demonstrates the translational potential of gramine in overcoming chemoresistance.

• Caspase-3 Fluorometric Assay Kit: Illuminating Apoptosis Pat

  2026-05-26

  Explore the scientific advances in apoptosis quantification enabled by the Caspase-3 Fluorometric Assay Kit. This in-depth review uniquely connects molecular insights from recent hyperthermia-cisplatin research to practical assay decisions, providing researchers with actionable strategies for caspase signaling pathway analysis.

• HyperScript First-Strand cDNA Synthesis Kit: Precision in RN

  2026-05-26

  The HyperScript First-Strand cDNA Synthesis Kit empowers researchers to generate high-fidelity cDNA from even the most challenging RNA samples, including those with low abundance or complex secondary structures. Its robust enzyme engineering and versatile primer options streamline transcriptomic workflows, enabling advanced gene expression analysis and reproducible PCR amplification.

• CD40–STING–TRAF2 Axis in B Cell Activation and TLS in ESCC

  2026-05-25

  This study identifies tertiary lymphoid structures (TLS) as an independent marker of favorable prognosis in esophageal squamous cell carcinoma (ESCC) and elucidates how competitive binding between CD40 and STING with TRAF2 drives IRF4-mediated B cell activation via non-canonical NF-κB signaling. These findings highlight new avenues for biomarker development and mechanistic investigation of antitumor immunity in ESCC.

• Canagliflozin Remodels Mitochondria in Diabetic Hypertensive

  2026-05-25

  This study demonstrates that canagliflozin, an SGLT2 inhibitor, improves both the structure and function of proximal tubular cell mitochondria in hypertensive–diabetic mice. These mitochondrial changes, especially prominent in males, suggest a mechanism for kidney protection that extends beyond glycemic control, offering new directions for metabolic and renal disease research.

8762 records 10/585 page Previous Next First page 上5页 678910 下5页 Last page